Comment on "MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma".

Details

Ressource 1Download: PMID29491129.pdf (49.57 [Ko])
State: Public
Version: Final published version
Serval ID
serval:BIB_0845E1BF99E5
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
UNIL/CHUV
Title
Comment on "MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma".
Journal
Haematologica
Author(s)
Voruz S., Martins F., Cairoli A., Naveiras O., Homicsko K., Missiaglia E., de Leval L., Bisig B., Michielin O., Blum S.
ISSN
1592-8721 (Electronic)
ISSN-L
0390-6078
Publication state
Published
Issued date
03/2018
Peer-reviewed
Oui
Volume
103
Number
3
Pages
e130
Language
english
Notes
Publication types: Journal Article ; Comment
Publication Status: ppublish
Keywords
Histiocytic Sarcoma, Humans, Imatinib Mesylate, Protein-Tyrosine Kinases, Pyridones, Pyrimidinones
URN
urn:nbn:ch:serval-BIB_0845E1BF99E56
OAI-PMH
oai:serval.unil.ch:BIB_0845E1BF99E5
DOI
10.3324/haematol.2017.186932
Pubmed
29491129
Web of science
000426478500010
Open Access
Yes
Create date
06/03/2018 9:34
Last modification date
21/11/2022 8:29
Usage data